Image de couverture de livre

Multifactorial attribution for vancomycin‐associated acute kidney injury

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yu‐Ling Tseng, Chien‐Chou Su, Ching‐Shiang Yang, Chun‐Hao Yin, Yi‐Chia Su
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	British Journal of Clinical Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis‐requiring acute kidney injury
par: Jui‐Yi Chen, et autres
Publié: (2025)

Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients
par: Yong Jin Lim, et autres
Publié: (2026)

Possible therapeutic repositioning of valproic acid: From epileptic seizures to acute kidney injury
par: Danilo Alves‐Bezerra, et autres
Publié: (2026)

Effectiveness and safety of combining thiazides with loop diuretics vs . loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study
par: Chia‐Chen Hsu, et autres
Publié: (2025)

Model‐informed vancomycin precision dosing by population pharmacokinetics combined with machine learning algorithms
par: Lei Shi, et autres
Publié: (2026)

Association of regular paracetamol or ibuprofen usage with the risk of incident kidney stones
par: Yiting Wu, et autres
Publié: (2025)

Propafenone‐ vs . amiodarone‐associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure
par: Yi‐Cheng Lin, et autres
Publié: (2025)

Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia
par: Marlotte A. A. van der Veer, et autres
Publié: (2024)

Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy
par: Lucy B. Palmer, et autres
Publié: (2024)

Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis
par: Qingfeng He, et autres
Publié: (2024)

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
par: Zoë Vander Elst, et autres
Publié: (2026)

External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high‐flux intermittent haemodialysis
par: Cheng Ji, et autres
Publié: (2024)

A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates
par: Mehdi El Hassani, et autres
Publié: (2024)

Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis
par: Laura Räisänen, et autres
Publié: (2025)

Practical dose ranges supporting target vancomycin exposure with AUC‐guided dosing in overweight and obese patients: A multicentre retrospective study
par: Aiju Endo, et autres
Publié: (2026)

Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period
par: Hui Yu, et autres
Publié: (2026)

Cardiovascular benefits of early sodium‐glucose cotransporter 2 inhibitor use for diabetics with acute myocardial infarction: A nationwide cohort study
par: Sheng‐Fan Wang, et autres
Publié: (2025)

Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study
par: Jumpei Taniguchi, et autres
Publié: (2026)

Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database
par: Zeng‐Xiang Zhao, et autres
Publié: (2024)

Letter to the editor regarding “Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study”
par: Satoru Mitsuboshi
Publié: (2026)

Letter to the editor—Response to the article “Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis”
par: Jaya Ranjalkar, et autres
Publié: (2025)

Recurrent fexuprazan‐induced liver injury following unintentional re‐exposure
par: Sook Jin Seong, et autres
Publié: (2025)

Epigenetic modifications in drug‐induced liver injury: A systematic review
par: Romina Lorena de los Santos‐Fernández, et autres
Publié: (2025)

Impact of antibiotics allergy labels on clinical outcomes in ICU patients: A 15‐year retrospective cohort study
par: Jiachun Su, et autres
Publié: (2026)

Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
par: Hongtao Yu, et autres
Publié: (2025)

Moving forward to ‘put people first’
par: Alice Tseng, et autres
Publié: (2024)

Janus kinase inhibitors for the treatment of lichen Sclerosus: A systematic review
par: Chin‐Hsuan Shen, et autres
Publié: (2025)

Fostamatinib and the risk of acute aortic dissection in immune thrombocytopenia
par: Paul Dalmas, et autres
Publié: (2025)

Longitudinal non‐cancer pain management patterns and risk of adverse outcomes in older adults: Insights from group‐based multi‐trajectory modelling
par: I‐Tzu Chen, et autres
Publié: (2025)

Virtual healthcare compared to hospital care for acute and post‐acute illness in adults: A systematic review and meta‐analysis of randomized controlled trials
par: Rana A. Malhis, et autres
Publié: (2025)

Altered bile acid and coproporphyrin‐I disposition in patients with autosomal dominant polycystic kidney disease
par: Jacqueline B. Tiley, et autres
Publié: (2024)

Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study
par: Sara Al Lawati, et autres
Publié: (2026)

Temporal effects of errors in estimating kidney function after critical illness on drug dosing categories
par: Ryusei Mikami, et autres
Publié: (2025)

Neurotoxicity from inordinate valacyclovir dosage in an elderly woman with stage 5 chronic kidney disease
par: Juan A. Vasquez Vasquez, et autres
Publié: (2025)

Medication review interventions for adults living with advanced chronic kidney disease: A scoping review
par: Cathy Margaret Pogson, et autres
Publié: (2024)

Comment on revisiting the association between anticholinergic burden and frailty in people with HIV
par: Yu Wang
Publié: (2026)

Evaluation of the acute effects of single‐dose TPN171 on semen quality in healthy Chinese male volunteers
par: Yuzhuo Yang, et autres
Publié: (2025)

Comment on ‘Renoprotective effects of dapagliflozin in diabetic patients with chronic kidney disease: A retrospective observational study’
par: Jia Chen, et autres
Publié: (2026)

Predicting potassium trajectories for risk monitoring in outpatients with heart failure, diabetes mellitus or chronic kidney disease
par: Camilo Scherkl, et autres
Publié: (2025)

Feasibility and evaluation of high‐fidelity simulation education for acute clinical toxicology
par: David J. Brinkman, et autres
Publié: (2024)